These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33811504)

  • 21. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
    Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
    Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    Matsuzaki Tada A; Hamezah HS; Pahrudin Arrozi A; Abu Bakar ZH; Yanagisawa D; Tooyama I
    J Alzheimers Dis; 2022; 89(3):835-848. PubMed ID: 35964178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
    J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrahydroxy Stilbene Glucoside Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice.
    Gao D; Chen C; Huang R; Yang CC; Miao BB; Li L; Zhang L
    Curr Med Sci; 2021 Apr; 41(2):279-286. PubMed ID: 33877543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
    Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.
    Jia YL; Wang W; Han N; Sun HL; Dong FM; Song YX; Feng RF; Wang JH
    Biochem Biophys Res Commun; 2023 May; 658():36-43. PubMed ID: 37018887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
    CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
    Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β‑asarone modulates Beclin‑1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease.
    Deng M; Huang L; Zhong X
    Mol Med Rep; 2020 May; 21(5):2095-2102. PubMed ID: 32186763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
    Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
    Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.